Close

Drug Research

Germany’s Merck KGaA acquires Mirus Bio for $600 M

Gamma Biosciences, a life sciences platform established by KKR to address the advanced therapy bioprocessing market, announced that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, whereby Merck KGaA, Darmstadt,...

Pharma Chemicals Market To Grow At A CAGR of 5% Till 2029

It is worth noting that the pharmaceutical chemicals market happens to be segmented by Type which includes Reagents, Catalysts, Solvents, KSMs and intermediates, Building Blocks for APIs and Advanced Intermediaries and by Application which has in it Medical Raw...

Europe API Market To Grow At A CAGR of Over 5.5% Till 2033

As per one of the recently held studies in 2024, the Europe Active Pharmaceutical Ingredients- API market size happened to be anticipated at $45.43 billion in 2023, and with an expected CAGR of 5.78% right from 2024 to 2033,...

Top Trends – Europe Active Pharmaceutical Ingredients Market

The active pharma ingredient market in Europe has been a matter of much discussion, and no wonder it has laid a very exclusive but at the same time elaborate market for itself. The European market has been experiencing innumerable trends...

Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical & Biotech Industry

Veranova and Phorum.AI announced that they are collaborating on next-generation optimization of pharmaceutical manufacturing processes using artificial intelligence (AI) Building on years of research and experimentation by Phorum.AI co-founder and MIT Professor of Chemistry, Brad Pentelute, Phorum.AI is deploying generative...

Singapore To Be Home To $1.5bn AstraZeneca Production Plant

On May 20, 2024, AstraZeneca, the global biopharma company, announced plans to build a $1.5 billion manufacturing facility in Singapore. With this announcement, the company is looking to start the design and construction of the new Singapore setup by...

Laboratory-Developed Tests Set To Be Regulated By The FDA

The FDA’s final rule that solidifies its presence and authority on Laboratory-Developed Tests- LDTs goes on to mark a prominent shift in the regulation as far as the diagnostics sector is concerned. The rule very well makes it pretty clear...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read